SE430885B - Oxytocin-derivat - Google Patents

Oxytocin-derivat

Info

Publication number
SE430885B
SE430885B SE8002222A SE8002222A SE430885B SE 430885 B SE430885 B SE 430885B SE 8002222 A SE8002222 A SE 8002222A SE 8002222 A SE8002222 A SE 8002222A SE 430885 B SE430885 B SE 430885B
Authority
SE
Sweden
Prior art keywords
oxytocin
derivatives
mpa
tyr
uterine
Prior art date
Application number
SE8002222A
Other languages
English (en)
Swedish (sv)
Other versions
SE8002222L (sv
Inventor
P O R Melin
Original Assignee
Ferring Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Ab filed Critical Ferring Ab
Priority to SE8002222A priority Critical patent/SE430885B/sv
Priority to US06/238,715 priority patent/US4402942A/en
Priority to CH140781A priority patent/CH646139A5/de
Priority to GB8106843A priority patent/GB2074582B/en
Priority to DE3108323A priority patent/DE3108323C2/de
Priority to NL8101191A priority patent/NL8101191A/nl
Priority to BE0/204141A priority patent/BE887970A/fr
Priority to FR8105751A priority patent/FR2482093A1/fr
Priority to JP4227581A priority patent/JPS56150050A/ja
Priority to IT20684/81A priority patent/IT1136574B/it
Publication of SE8002222L publication Critical patent/SE8002222L/xx
Publication of SE430885B publication Critical patent/SE430885B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8002222A 1980-03-24 1980-03-24 Oxytocin-derivat SE430885B (sv)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SE8002222A SE430885B (sv) 1980-03-24 1980-03-24 Oxytocin-derivat
US06/238,715 US4402942A (en) 1980-03-24 1981-02-27 Oxytocin derivatives
CH140781A CH646139A5 (de) 1980-03-24 1981-03-03 Oxytocin-derivate.
GB8106843A GB2074582B (en) 1980-03-24 1981-03-04 Oxytocin-derivatives
DE3108323A DE3108323C2 (de) 1980-03-24 1981-03-05 1-Desamino (2-O-alkyltyrosin)-oxytocine und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
NL8101191A NL8101191A (nl) 1980-03-24 1981-03-11 Oxytocine derivaat; farmaceutisch preparaat; werkwijze voor het tegengaan van spiercontracties van de uterus.
BE0/204141A BE887970A (fr) 1980-03-24 1981-03-16 Nouveaux derives d'ocytocine et compositions pharmaceutiques contenant ces derives
FR8105751A FR2482093A1 (fr) 1980-03-24 1981-03-23 Nouveaux derives d'ocytocine et compositions pharmaceutiques contenant ces derives
JP4227581A JPS56150050A (en) 1980-03-24 1981-03-23 Oxitocin derivative
IT20684/81A IT1136574B (it) 1980-03-24 1981-03-24 Derivati della ossitocina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8002222A SE430885B (sv) 1980-03-24 1980-03-24 Oxytocin-derivat

Publications (2)

Publication Number Publication Date
SE8002222L SE8002222L (sv) 1981-09-25
SE430885B true SE430885B (sv) 1983-12-19

Family

ID=20340577

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8002222A SE430885B (sv) 1980-03-24 1980-03-24 Oxytocin-derivat

Country Status (10)

Country Link
US (1) US4402942A (it)
JP (1) JPS56150050A (it)
BE (1) BE887970A (it)
CH (1) CH646139A5 (it)
DE (1) DE3108323C2 (it)
FR (1) FR2482093A1 (it)
GB (1) GB2074582B (it)
IT (1) IT1136574B (it)
NL (1) NL8101191A (it)
SE (1) SE430885B (it)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4504469A (en) * 1982-12-21 1985-03-12 Ferring Ab Vasotocin derivatives
SE8207277L (sv) * 1982-12-21 1984-06-22 Ferring Ab Vasotocin-derivat
US4483794A (en) * 1983-05-10 1984-11-20 Ceskoslovenska Akademie Ved Analogs of neurohypophysial hormones
US4624943A (en) * 1985-03-20 1986-11-25 Smithkline Beckman Corporation Aromatic basic-tailed vasopressin antagonists
US5225528A (en) * 1990-02-27 1993-07-06 Merck & Co., Inc. Cyclic hexapeptide oxytocin antagonists
DE4042008A1 (de) * 1990-12-22 1992-06-25 Schering Ag Vasopressin-derivate
US5830848A (en) * 1992-10-09 1998-11-03 The Regents Of The University Of California Method and agents for inducement of endogenous nitric oxide synthase for control and management of labor during pregnancy
US6933417B1 (en) 1999-11-22 2005-08-23 Dow Global Technologies Inc. Process for vinyl chloride manufacture from ethane and ethylene with partial CHl recovery from reactor effluent
US6797845B1 (en) 1999-11-22 2004-09-28 Dow Global Technologies Inc. Process for vinyl chloride manufacture from ethane and ethylene with immediate HCl recovery from reactor effluent
US6909024B1 (en) * 1999-11-22 2005-06-21 The Dow Chemical Company Process for the conversion of ethylene to vinyl chloride and novel catalyst compositions useful for such process
US6680415B1 (en) * 1999-11-22 2004-01-20 Dow Global Technologies Inc. Oxyhalogenation process using catalyst having porous rare earth halide support
SE0100684D0 (sv) * 2001-02-28 2001-02-28 Kerstin Uvnaes Moberg New subject-matter
CA2448500C (en) * 2001-05-23 2009-11-17 Dow Global Technologies Inc. Oxidative halogenation and optional dehydrogenation of c3+ hydrocarbons
US20040152929A1 (en) * 2002-05-08 2004-08-05 Clarke William D Process for vinyl chloride manufacture from ethane and ethylene with air feed and alternative hcl processing methods
US7722733B2 (en) 2004-03-29 2010-05-25 Baxter International Inc. Method for sterile connection of tubing
TWI463990B (zh) * 2009-09-21 2014-12-11 Ferring Bv 催產素受體促進劑
WO2016067252A1 (en) 2014-10-31 2016-05-06 Glaxosmithkline Intellectual Property Development Limited Powder formulation
AU2017205670B2 (en) 2016-01-04 2021-05-20 Merck Serono S.A. L-valinate of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof
WO2018015497A2 (en) 2016-07-21 2018-01-25 ObsEva S.A. Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage
WO2020137880A1 (ja) * 2018-12-27 2020-07-02 国立大学法人北海道大学 オキシトシン誘導体及びその使用
CA3149898A1 (en) 2019-09-03 2021-03-11 Ernest Loumaye Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage
CA3167121A1 (en) 2020-02-10 2021-08-19 ObsEva S.A. Biomarkers for oxytocin receptor antagonist therapy
US20240024294A1 (en) 2020-11-16 2024-01-25 Xoma (Us) Llc Compositions and methods for the treatment or prevention of preterm labor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1463865A (fr) * 1964-07-27 1966-07-22 Ceskoslovenska Akademie Ved Procédé pour la préparation des dérivés cycliques de peptides ainsi que les produits conformes à ceux obtenus par le présent procédé ou procédé similaire
CS194980B1 (en) * 1976-07-16 1979-12-31 Joseph H Cort Agent for current induction,fertilization facilitating and milkability increasing at mammals,especially at utility cattle

Also Published As

Publication number Publication date
CH646139A5 (de) 1984-11-15
US4402942A (en) 1983-09-06
DE3108323C2 (de) 1983-11-24
JPS56150050A (en) 1981-11-20
BE887970A (fr) 1981-07-16
FR2482093B1 (it) 1984-11-09
SE8002222L (sv) 1981-09-25
GB2074582B (en) 1983-07-06
FR2482093A1 (fr) 1981-11-13
NL8101191A (nl) 1981-10-16
IT8120684A0 (it) 1981-03-24
IT1136574B (it) 1986-09-03
GB2074582A (en) 1981-11-04
DE3108323A1 (de) 1981-12-24

Similar Documents

Publication Publication Date Title
SE430885B (sv) Oxytocin-derivat
CA2189250C (en) Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
EP0679092B1 (en) Cytokine restraining agents
Melin et al. Synthetic antagonists of the myometrial response to vasopressin and oxytocin
US5763404A (en) Methods for using LHRH antagonists with low histamine release
US5786332A (en) Cytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levels
JP3405460B2 (ja) ヘプタペプチドオキシトシン類似体
US5480869A (en) Anti-inflammatory peptide analogs and treatment to inhibit vascular leakage in injured tissues
CA1216843A (en) Vasotocin derivatives
IE840867L (en) Peptides
US20240083941A1 (en) Inhibitors of nf kappa-b activity for treatment of diseases and disorders
CA2068312A1 (en) Agent for neutralising the procoagulant activity associated with tumor cells
Melin et al. Inhibitory effect of O-alkylated analogues of oxytocin and vasopressin on human and rat myometrial activity
CA2072253A1 (en) Anti-inflammatory peptides and treatment to inhibit vascular leakage in injured tissues
KR100244624B1 (ko) 황체 형성 호르몬 방출 호르몬(lhrh) 길항제 및 이를 함유하는 약제학적 조성물
HU216733B (hu) Eljárás vaszkuláris szivárgás gátlására alkalmas gyógyszerészeti készítmények előállítására
KR100291304B1 (ko) 옥시토신 길항제
KR102417762B1 (ko) 펜타펩타이드 및 그 용도
IE912378A1 (en) Derivatives of pituitary posterior lobe hormones
US4956344A (en) Method for treatment of lesions in the large intestinal epithelium with a tripeptide
EP0394283B1 (en) Use of a tripeptide for the preparation of pharmaceutical compositions and a pharmaceutical composition and method
SU1083560A1 (ru) Гептапептид,обладающий способностью ингибировать миотропное действие брадикинина
Freer et al. Organ selective angiotensin antagonists: sarcosyl1-cysteinyl (S-methyl) 8-angiotensin I
WO1995007705A1 (en) Method for inhibiting vascular leakage and anti-inflammatory compounds
CZ993A3 (en) derivatives of neurohypophysis lobe hormones

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8002222-1

Effective date: 19890426

Format of ref document f/p: F